PLA2G2D Antikörper (AA 21-145)
Kurzübersicht für PLA2G2D Antikörper (AA 21-145) (ABIN7570748)
Target
Alle PLA2G2D Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 21-145
-
Verwendungszweck
- Anti-PLA2G2D Polyclonal antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human PLA2G2D (Gly21-Cys145).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- PLA2G2D (Phospholipase A2, Group IID (PLA2G2D))
-
Andere Bezeichnung
- PLA2G2D
-
Hintergrund
- PLA2IID,SPLASH,Group IID secretory phospholipase A2,sPLA2-IID,Secretory-type PLA,stroma-associated homolog,GIID sPLA2,Phosphatidylcholine 2-acylhydrolase 2D,PLA2G2D,
-
UniProt
- Q9UNK4
-
Pathways
- Inositol Metabolic Process
Target
-